Leanbio member of organizing committee 5th European Biosimilars Congress

Leanbio has recently become a member of the organizing committee of the 5th European Biosimilars Congress, to be held in Valencia on the 27-29th of June 2016.  Our company will, as well, organize in it a workshop focusing on the strategy for the development of Biosimilars, with deep insight in Cell line development, Upstream processing development, Downstream processing development, Formulation development and Analytical development as key part Biosimilar projects. Leanbio develops products from POC to Market through a patent and fee-free approach with Freedom to Operate for our clients, following a QbD approach and minimizing time to market.